US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Arin Tactical Tail Risk ETF

95.88

-0.0628-0.07%

Volume:16

Turnover:1.54K

Market Cap:114.97M

PE:- -

High:95.88

Open:95.88

Low:95.88

Close:95.94

52wk High:96.17

52wk Low:45.10

Shares:1.20M

Float Shares:1.20M

Volume Ratio:0.02

T/O Rate:0.00%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Ionis, AstraZeneca ATTR-CM trial did not meet primary endpoint

Japanese Shares Rise Ahead of Federal Reserve Chair's Rate Outlook; Oil Falls

MT Newswires Live

Bayer’s MOSAIC-TTR Study: Real-World Data Push for Acoramidis in ATTR-CM

BridgeBio Pharma doses first patient in ASCEND-ATTR trial

BridgeBio Announces First Participant Dosed in ASCEND-ATTR, a Phase 3b/4 Study Evaluating the Long-Term Effects of Acoramidis on Disease Regression in ATTR-CM

Alert Signals Intensify: UBS Flags U.S. Stock Market Fragility at Two-Year High, Echoing Pattern That Preceded VIX Spike

Alnylam to present new clinical data on ATTR, hypertension at ESC Congress

BridgeBio to Present New Acoramidis Data from Open-Label Extension Analyses in ATTR-CM at ESC Congress 2026

The Bond Selloff is Rattling Investors, but Here's Why They Shouldn't Expect a Deeper Stock Downturn

Banco Santander receives Federal Reserve approval for Webster acquisition

A Federal Reserve Stuck in Limbo

Alnylam Lowers 2026 Outlook As Second-Line Amvuttra Demand Normalizes, Stock Tanks

Benzinga Earnings

Southbound 2x Long Nikkei ETF (07262) Drops Over 5% Intraday as Korean Index Plunge Fuels Market Risk Aversion

Risk Aversion Fades, USD/JPY Holds High-Level Consolidation

Surge in Oil Prices Stirs Rate Hike Fears; US Bond Yields Climb, Wall Street Sounds Correction Alarm

Market Risk Aversion Eases, US Dollar Index Ends Slightly Lower

Royalty Pharma acquires royalty interest in AstraZeneca’s cliramitug for up to $425 million from Neurimmune

Alnylam Pharmaceuticals (ALNY) Could Be 28% Undervalued Following Rival ATTR Trial Failure

Simply Wall St.

Acoramidis Associated with First-Ever Early and Sustained Direct Kidney-Protective Effects in ATTR-CM

DKSH Partners with BridgeBio to Distribute ATTR-CM Drug in Key Asia-Pacific Markets

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/ATTR/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ATTR","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ATTR\",,,,,undefined,":{"symbol":"ATTR","market":"US","secType":"STK","nameCN":"Arin Tactical Tail Risk ETF","latestPrice":95.88,"timestamp":1790952104808,"preClose":95.9428,"halted":0,"volume":16,"delay":0,"changeRate":-0.0006545566733513089,"floatShares":1199146,"shares":1199146,"eps":0,"marketStatus":"Trading","change":-0.0628,"latestTime":"10-02 11:02:06 EDT","open":95.88,"high":95.88,"low":95.88,"amount":1539.83056,"amplitude":0,"askPrice":96.33,"askSize":500,"bidPrice":96.23,"bidSize":500,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1790971200000},"marketStatusCode":2,"adr":0,"exchange":"CBOE","adjPreClose":95.9428,"sharesOutstanding":989146,"nav":95.92,"aum":115022084.32,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":95.94,"preClose":95.9428,"latestTime":"07:00 EDT","volume":1,"amount":95.94,"timestamp":1790938814620,"change":-0.0028,"changeRate":-0.000029,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":95.8999,"preClose":95.9428,"latestTime":"16:10 EDT","volume":7,"amount":671.5996,"timestamp":1790885404512,"change":-0.0429,"changeRate":-0.000447,"amplitude":0},"volumeRatio":0.020161},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ATTR\",,,,,undefined,":{"symbol":"ATTR","floatShares":1199146,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.020161,"shares":1199146,"dividePrice":0,"high":95.88,"amplitude":0,"preClose":95.9428,"low":95.88,"week52Low":45.1,"pbRate":"--","week52High":96.165,"institutionHeld":0,"latestPrice":95.88,"eps":0,"divideRate":0,"volume":16,"delay":0,"ttmEps":0,"open":95.88,"prevYearClose":90.4492,"prevWeekClose":96.1432,"prevMonthClose":95.9499,"prevQuarterClose":95.9499,"fiveDayClose":96.1432,"twentyDayClose":95.5746,"sixtyDayClose":94.5347},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ATTR\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ATTR\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ATTR\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ATTR\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662093409","title":"Ionis, AstraZeneca ATTR-CM trial did not meet primary endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2662093409","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662093409?lang=en_us&edition=fundamental","pubTime":"2026-08-28 20:50","pubTimestamp":1787921430,"startTime":"0","endTime":"0","summary":"The CARDIO-TTRansform trial investigating eplontersen in patients with transthyretin-mediated amyloid cardiomyopathy did not meet its primary effic...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ionis-astrazeneca-attr-cm-trial-did-not-meet-primary-endpoint-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ionis-astrazeneca-attr-cm-trial-did-not-meet-primary-endpoint-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ATTR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662973052","title":"Japanese Shares Rise Ahead of Federal Reserve Chair's Rate Outlook; Oil Falls","url":"https://stock-news.laohu8.com/highlight/detail?id=2662973052","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662973052?lang=en_us&edition=fundamental","pubTime":"2026-08-28 15:31","pubTimestamp":1787902301,"startTime":"0","endTime":"0","summary":"Japanese stocks gained marginally on Friday after US Treasury yields steadied, while investors remained cautious ahead of Federal Reserve Chair Kevin Warsh's speech at Jackson Hole on the outlook for US interest rates.The benchmark Nikkei 225 closed up 273.58 points, or 0.41%, at 66,405.56.Oil prices extended losses following an Iran-Oman deal to impose a tariff on traffic in the Strait of Hormuz on a revenue-sharing basis, even as hopes of direct US-Iran talks remain uncertain.On the corporate side, Nissan Motor's  global sales fell about 17% year over year to 219,495 units in July, according to a statement on Friday.Also, Toyota Motor  posted its sixth consecutive drop in worldwide monthly sales in July, with group-wide volume falling 5.3% year over year to 912,683 vehicles, according to company data released Friday.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["EBND","HF","US10Y.BOND","ATTR","RORO","EOPS","PSQ","DBMF","ARKD","VTV","OGSP","PLGI","CDIG","VEXC","LQ","ITDH","HIDV","MFMO","SDHY","VOOV","BAMO","EMPB","RGLO","WLDR","FITZ","US12M.BOND","QUSA","RULE","BAMA","EQIN","CGDV","KOOL","SPBW","PEMX","CAOS","DVUT","NELS","JULD","EQRR","BKIV","BINT","RJZ","QIS","SOVF","NSCI","SGRT","MDPL","SLTY","FT","DADS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662181084","title":"Bayer’s MOSAIC-TTR Study: Real-World Data Push for Acoramidis in ATTR-CM","url":"https://stock-news.laohu8.com/highlight/detail?id=2662181084","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662181084?lang=en_us&edition=fundamental","pubTime":"2026-08-28 00:31","pubTimestamp":1787848296,"startTime":"0","endTime":"0","summary":"Bayer AG ($BAYRY) announced an update on their ongoing clinical study. The MOSAIC-TTR study, officially titled “A Prospective, Longitudinal, Multi-...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bayers-mosaic-ttr-study-real-world-data-push-for-acoramidis-in-attr-cm?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bayers-mosaic-ttr-study-real-world-data-push-for-acoramidis-in-attr-cm?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ATTR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662468716","title":"BridgeBio Pharma doses first patient in ASCEND-ATTR trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2662468716","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662468716?lang=en_us&edition=fundamental","pubTime":"2026-08-26 19:45","pubTimestamp":1787744721,"startTime":"0","endTime":"0","summary":"BridgeBio Pharma (BBIO) announced that the first participant has been dosed in ASCEND-ATTR, a Phase 3b/4 study designed to further characterize the...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bridgebio-pharma-doses-first-patient-in-ascend-attr-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bridgebio-pharma-doses-first-patient-in-ascend-attr-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ATTR","BK4585","BK4139","BK4588","BK4505","BBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662715763","title":"BridgeBio Announces First Participant Dosed in ASCEND-ATTR, a Phase 3b/4 Study Evaluating the Long-Term Effects of Acoramidis on Disease Regression in ATTR-CM","url":"https://stock-news.laohu8.com/highlight/detail?id=2662715763","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662715763?lang=en_us&edition=fundamental","pubTime":"2026-08-26 19:30","pubTimestamp":1787743800,"startTime":"0","endTime":"0","summary":"- The ASCEND-ATTR study builds on the Phase 3 ATTRibute-CM CMR substudy results previously shared here, which indicated treatment with acoramidis may improve cardiac structure and function with eviden","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/26/3351235/0/en/bridgebio-announces-first-participant-dosed-in-ascend-attr-a-phase-3b-4-study-evaluating-the-long-term-effects-of-acoramidis-on-disease-regression-in-attr-cm.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4207","ATTR","CM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178549106","title":"Alert Signals Intensify: UBS Flags U.S. Stock Market Fragility at Two-Year High, Echoing Pattern That Preceded VIX Spike","url":"https://stock-news.laohu8.com/highlight/detail?id=1178549106","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178549106?lang=en_us&edition=fundamental","pubTime":"2026-08-25 19:07","pubTimestamp":1787656034,"startTime":"0","endTime":"0","summary":"Fragility is quietly building within the U.S. stock market. On August 25, MarketWatch reported that UBS's \"Turbu-lens\" index, a proprietary gauge designed to measure market fragility, has recently...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPXU","SPYM","SVIX","UVIX","DMAX","VVIX","SMAX","WDTE","SDS","YSPY","XDTE","UPRO","VOO","USMV","SH","SPXL","TVIXF","QQQY","SPY","SPYQ","SVOL","SVXY","VIXmain","VIXM","FLAO","OCTQ","VYLD","DFUS","ODTE","BK4588","HIBL","MMAX","TVIX","DECU","SPYH","ATTR","IVV","SPYU","VIXY","VXZ","SPXS","UVXY","SPUU","MSTB","BK4585","ZHDG","SSO","VIX","SPDN","VXX","VXMmain","DECP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661279552","title":"Alnylam to present new clinical data on ATTR, hypertension at ESC Congress","url":"https://stock-news.laohu8.com/highlight/detail?id=2661279552","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661279552?lang=en_us&edition=fundamental","pubTime":"2026-08-24 20:40","pubTimestamp":1787575225,"startTime":"0","endTime":"0","summary":"Alnylam (ALNY) Pharmaceuticals announced that it will present new clinical and real-world data across its transthyretin-mediated amyloidosis, ATTR,...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/alnylam-to-present-new-clinical-data-on-attr-hypertension-at-esc-congress-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/alnylam-to-present-new-clinical-data-on-attr-hypertension-at-esc-congress-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0109394709.USD","BK4139","BK4585","BK4588","BK4548","LU0320765992.SGD","LU0889565916.HKD","ATTR","LU0114720955.EUR","PBE","LU0882574055.USD","ALNY","GNMX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661275001","title":"BridgeBio to Present New Acoramidis Data from Open-Label Extension Analyses in ATTR-CM at ESC Congress 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2661275001","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661275001?lang=en_us&edition=fundamental","pubTime":"2026-08-24 19:30","pubTimestamp":1787571000,"startTime":"0","endTime":"0","summary":"PALO ALTO, Calif., Aug.  24, 2026 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a biopharmaceutical company focused on developing medicines for genetic cond","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/24/3349646/0/en/bridgebio-to-present-new-acoramidis-data-from-open-label-extension-analyses-in-attr-cm-at-esc-congress-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATTR","BK4081","EMA","BK4207","CM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660447732","title":"The Bond Selloff is Rattling Investors, but Here's Why They Shouldn't Expect a Deeper Stock Downturn","url":"https://stock-news.laohu8.com/highlight/detail?id=2660447732","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660447732?lang=en_us&edition=fundamental","pubTime":"2026-08-19 19:22","pubTimestamp":1787138520,"startTime":"0","endTime":"0","summary":"Strategist Mark Newton flags signs of technical resilienceResilient financial stocks are one signal the bond-market rout won't drive a bigger equity selloff, says Fundstrat.While the bond market sello","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["US2Y.BOND","TVIXF","VIXmain","US7Y.BOND","ISBC","SPXU","IVV","TLTW","LOW","SKDD","SKHU","TMF","US6M.BOND","SPYU","VIXY","HIBL","HYNX","VVIX","SKHX","SPXS","SKUU","US3Y.BOND","US12M.BOND","SKHYV","USMV","DMAX","VIXM","US30Y.BOND","VYLD","SPXL","SKHZ","FLAO","US10Y.BOND","SPYH","SVIX","SPY","TJX","ATTR","TLT","SPDN","SVOL","SPYQ","SKHY","US5Y.BOND","VXZ","SH","YSPY","SPUU","SMAX","UPRO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657598758","title":"Banco Santander receives Federal Reserve approval for Webster acquisition","url":"https://stock-news.laohu8.com/highlight/detail?id=2657598758","media":"TIPRANKS","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657598758?lang=en_us&edition=fundamental","pubTime":"2026-08-05 07:00","pubTimestamp":1785884429,"startTime":"0","endTime":"0","summary":"Banco Santander (SAN) and Webster Financial (WBS) announced that they have received the required approval from the Board of Governors of the Federa...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/banco-santander-receives-federal-reserve-approval-for-webster-acquisition-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/banco-santander-receives-federal-reserve-approval-for-webster-acquisition-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["JPO","ATTR","CGDV","OGSP","US10Y.BOND","PAYH","OCTU","PSQ","BAMO","ZSEP","LALT","EQRR","DBMF","AMZY","SCLZ","ARKD","FLSP","QUSA","WLDR","AAUB","DVUT","WBS","US30Y.BOND","FDLO","US3Y.BOND","SLTY","GXDW","FLDZ","PLGI","NELS","LVLN","CPNM","SSEUF","VTV","EOPS","BGH","BUFH","HFEQ","EQIN","SPBW","US7Y.BOND","SOVF","FITZ","GDMA","BINT","US12M.BOND","QIS","CAOS","ISSXF","HF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655361590","title":"A Federal Reserve Stuck in Limbo","url":"https://stock-news.laohu8.com/highlight/detail?id=2655361590","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655361590?lang=en_us&edition=fundamental","pubTime":"2026-07-31 21:15","pubTimestamp":1785503700,"startTime":"0","endTime":"0","summary":"Federal Reserve Chairman Kevin Warsh's second press conference this week left many confused, including reporters and economists like me who closely follow the Fed. Markets temporarily reacted negative","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EOPS","VEXC","OGSP","US30Y.BOND","SIXH","SPBW","RAAA","RULE","PAYH","PLGI","SLTY","BAMO","VTV","FITZ","MFMO","SCLZ","GDMA","BAMA","US7Y.BOND","QIS","FLSP","HF","HIDV","DVUT","RGLO","JULD","KHPI","BUFH","ITDH","NELS","AMZY","ARKD","US6M.BOND","EBND","EQIN","EQRR","ATTR","CGDV","OCTM","DBMF","US2Y.BOND","FARX","NQLT","US10Y.BOND","FT","LQ","US5Y.BOND","US3Y.BOND","US12M.BOND","PBQQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655800918","title":"Alnylam Lowers 2026 Outlook As Second-Line Amvuttra Demand Normalizes, Stock Tanks","url":"https://stock-news.laohu8.com/highlight/detail?id=2655800918","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655800918?lang=en_us&edition=fundamental","pubTime":"2026-07-31 02:37","pubTimestamp":1785436635,"startTime":"0","endTime":"0","summary":"Alnylam cut its 2026 sales outlook despite a Q2 earnings beat as slower ATTR-CM market growth weighed on expectations and investors reacted.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/earnings/26/07/60815910/alnylam-lowers-2026-outlook-as-second-line-amvuttra-demand-normalizes-stock-tanks","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0128525929.USD","LU0310800379.SGD","LU1267930573.SGD","PBE","LU2468319806.SGD","LU2462157665.USD","LU0058720904.USD","LU0289739699.SGD","LU0320765992.SGD","LU2236285917.USD","ATTR","BK4585","IONS","BK4588","LU2237443895.HKD","LU2237443978.SGD","AZNH","LU0029864427.USD","LU0882574055.USD","LU2456880835.USD","IE00B3T34201.USD","LU0109394709.USD","BK4548","LU0889565916.HKD","LU2237443549.SGD","BK4007","BK4139","BK4568","LU1829250122.USD","LU2089984988.USD","LU0708994859.HKD","LU0432979614.USD","LU2237443622.USD","LU2417539215.USD","AZN","LU2237443382.USD","LU2237443465.HKD","LU0114720955.EUR","ALNY","GNMX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102686498","title":"Southbound 2x Long Nikkei ETF (07262) Drops Over 5% Intraday as Korean Index Plunge Fuels Market Risk Aversion","url":"https://stock-news.laohu8.com/highlight/detail?id=1102686498","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102686498?lang=en_us&edition=fundamental","pubTime":"2026-07-29 14:38","pubTimestamp":1785307103,"startTime":"0","endTime":"0","summary":"The Southbound 2x Long Nikkei ETF (07262) fell more than 5% during intraday trading. As of press time, it was down 3.61% to 153.6 Hong Kong dollars, with a turnover of 65.8388 million Hong Kong...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IVV","BTYS","KNOW","DSCF","AOM","BK4585","TYLD","SPY","SDOW","BK4550","SPXS","HIBL","ILOW","ONOF","FDN","TPHE","MMAX","SNUG","YSPY","SPXL","GHTA","TFPN","SH","SPYM","LALT","THMR","WBIF","QQH","SMAX","SELV","UPRO","RORO","SDS","SPMV","ARP","LFEQ","DMAX","QAI","DMRS","DIA","DDM","SPDN","PTMC","SSO","CPSL","DBMF","HF","CLSM","ROMO","BDVL","QPT","BK4588","IALT","DXD","DOG","07262","VOO","HDG","SPUU","RHRX","FAIL","FARX","RPHS","UDOW","RHTX","VXZ","MFUT","SPXU","PRMN","QLS","CIL","VIXY","LOWV","ATTR","SPYQ","SPYH","SPYU","MOOD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114570494","title":"Risk Aversion Fades, USD/JPY Holds High-Level Consolidation","url":"https://stock-news.laohu8.com/highlight/detail?id=1114570494","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114570494?lang=en_us&edition=fundamental","pubTime":"2026-07-27 16:50","pubTimestamp":1785142245,"startTime":"0","endTime":"0","summary":"The USD/JPY pair continued its pullback during Asian trading on Monday, hovering near the 163.60 mark. An improvement in market risk sentiment has diminished the safe-haven demand for the US dollar....","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DMAX","MFUT","QLS","QQH","AOM","IALT","PTMC","SPMV","SPUU","DDM","TYLD","DOG","KNOW","BK4585","LFEQ","FARX","RHTX","UDOW","DBMF","SPXL","IVV","SPYM","TFPN","SDOW","SPDN","VXZ","QPT","BTYS","SNUG","HF","BK4588","LALT","DXD","ARP","ATTR","DSCF","GHTA","LOWV","SPYH","PRMN","SPYU","HDG","BDVL","FOXY","VOO","DMRS","RPHS","CLSM","DIA","RORO","SPXU","THMR","YSPY","ROMO","CPSL","RHRX","HIBL","FAIL","CIL","ILOW","MMAX","SELV","SSO","SPXS","TPHE","UPRO","VIXY","MOOD","SDS","WBIF","ONOF","SPYQ","QAI","SMAX","SH","SPY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144804077","title":"Surge in Oil Prices Stirs Rate Hike Fears; US Bond Yields Climb, Wall Street Sounds Correction Alarm","url":"https://stock-news.laohu8.com/highlight/detail?id=1144804077","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1144804077?lang=en_us&edition=fundamental","pubTime":"2026-07-25 09:50","pubTimestamp":1784944239,"startTime":"0","endTime":"0","summary":"Where to Focus First As the Middle East conflict intensifies and global oil prices surge, US Treasury yields have climbed to levels that unsettle stock investors. There is growing concern that...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DLMY","DYHG","DNOV","BNO","PXJ","BUFT","USOI","ALDB","BK4196","FNGS","SCHX","BK4570","SPIN","CAIE","DXD","VAIE","USPX","BJUN","XBJL","MMAR","EXEQ","VTHR","POCT","RECI","FJUL","SDOG","BK4585","DUG","IEO","IYY","OAKM","SPXL","UBmain","TPOR","BBUS","FAZ","GUSH","DDTM","ZTmain","GSLC","MAYU","UPRO","DFEB","FLAO","BK4581","BKLG","SMAX","ERX","IBTL","HAPR","JMOM","OCDB","AAUA","SCDL","ZNmain","FTXN","XYLG","USE","DBO","ZBmain","DBC","UJAN","IVV","QBQF","XBOC","SPDN","DBE","DRLL","BSTP","ILCB","HEQ","JANP","TRTY","CPNM","MFMO","XVOL","DIG","VOO","BMVP","SAMM","XSPI","DMAX","OILT","BFRZ","FEX","GQI","QB","SDOW","WAMA","CPNQ","XXV","YSPY","KSPY","BAPR","PXE","UTRN","XES","QCJA","XLUX","SPYQ","VDE","MBOX","SIXA","RSSY","BFEB","DDFM","ZFmain","SPY","LDER","SPHQ","SVOL","UDOW","BUFD","MRCP","BUFR","JULD","MTUL","SPXT","MSLC","CPSR","NYSX","UDEC","TPAY","OILK","RSSE","SPYM","STOX","WBIL","KHPI","RSEE","UJUL","FNDX","VTG","JUNW","DDFD","UAE","DOG","BFEW","EDGE","IBTB","SPYH","OIH","TSYX","SPYU","USL","SCLZ","DDEC","SPUU","TDAX","STRV","TNmain","GVLE","GOVM","ACLC","PBJA","EQL","AESR","ONEO","UGA","FMTM","EQTY","MPAY","WEEI","BXMX","PBSE","UTES","XLEX","BWET","XNTK","DDM","OILU","ALTL","XBFR","DYNF","FFA","SSO","SDS","CPSU","DRIP","WTIU","EBND","PSMR","FFLG","MBCE","VOOV","FTA","MMAX","PEJ","IXC","VFMO","OBIL","SPXU","BK4588","QJN","SPYT","ATTR","FLV","HIBL","BK4550","GOCT","SH","GSUS","DIA","SPXS","CPSM","IUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196049731","title":"Market Risk Aversion Eases, US Dollar Index Ends Slightly Lower","url":"https://stock-news.laohu8.com/highlight/detail?id=1196049731","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1196049731?lang=en_us&edition=fundamental","pubTime":"2026-07-23 17:21","pubTimestamp":1784798462,"startTime":"0","endTime":"0","summary":"On July 23rd, data released by the UK's Office for National Statistics on Wednesday showed that the UK's Consumer Price Index (CPI) rose by 2.6% year-on-year in June, marking the lowest level since...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATTR","DSCF","CADmain","LALT","RHTX","VXZ","FARX","SPYQ","DZZ","ONOF","VIXY","MEURmain","USCI","MFUT","DULL","FGDL","AOM","SHNY","BAR","RHRX","IVV","SPMV","EUO","CMCI","BK4585","LOWV","GCC","ULE","SPXS","SPDN","GLDN","FXE","AAAU","RORO","UDN","FXC","SPXU","YSPY","CHFmain","GBPmain","GLL","SH","TYLD","IAUM","FXY","LFEQ","BDVL","USLV","MOOD","GLDM","CLSM","MJYmain","HDG","UGL","SPXL","UPRO","GLDY","PTMC","EURmain","MGBPmain","YGLD","AUDmain","SDOW","HF","USDU","CPSL","SNUG","DBMF","TFPN","KGLD","SMAX","WBIF","THMR","DXD","PRMN","DMRS","WGLD","FXF","UGLD","SDS","BK4588","BGLD","QAI","ILOW","ROMO","HIBL","IAU","TPHE","SELV","QPT","YCS","DOG","BTYS","DGZ","QQH","DGP","IAUI","MCDmain","USG","KNOW","RPHS","GLD","SGOL","USDindex.FOREX","IALT","SPYH","JPYmain","ARP","IGLD","DMAX","MAUDmain","MMAX","DDM","QLS","VOO","NZDmain","FGLD","UUP","GHTA","SPY","OUNZ","CIL","MSFmain","FXB","SPUU","SSO","UDOW","DIA","SPYM","FXA","SPYU","FAIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653752839","title":"Royalty Pharma acquires royalty interest in AstraZeneca’s cliramitug for up to $425 million from Neurimmune","url":"https://stock-news.laohu8.com/highlight/detail?id=2653752839","media":"GlobeNewswire","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653752839?lang=en_us&edition=fundamental","pubTime":"2026-07-22 19:05","pubTimestamp":1784718300,"startTime":"0","endTime":"0","summary":"NEW YORK, July  22, 2026 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it has acquired a portion of Neurimmune’s royalty interest in AstraZeneca’s cliramitug for up to $42","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/22/3331241/0/en/Royalty-Pharma-acquires-royalty-interest-in-AstraZeneca-s-cliramitug-for-up-to-425-million-from-Neurimmune.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATTR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650199138","title":"Alnylam Pharmaceuticals (ALNY) Could Be 28% Undervalued Following Rival ATTR Trial Failure","url":"https://stock-news.laohu8.com/highlight/detail?id=2650199138","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650199138?lang=en_us&edition=fundamental","pubTime":"2026-07-10 20:29","pubTimestamp":1783686596,"startTime":"0","endTime":"0","summary":"Why Alnylam Pharmaceuticals Stock Is Back in Focus\nAlnylam Pharmaceuticals (ALNY) moved sharply higher after a late stage trial for a competing transthyretin amyloid cardiomyopathy treatment from AstraZeneca and Ionis Pharmaceuticals failed, shifting investor attention toward Alnylam’s ATTR portfolio.\nSee our latest analysis for Alnylam Pharmaceuticals.\nThat ATTR news lands on top of a mixed year for Alnylam Pharmaceuticals, with the share price at $312.79, a year to date share price decline...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-alny/alnylam-pharmaceuticals/news/alnylam-pharmaceuticals-alny-could-be-28-undervalued-followi","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-alny/alnylam-pharmaceuticals/news/alnylam-pharmaceuticals-alny-could-be-28-undervalued-followi","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0109394709.USD","LU0882574055.USD","LU0889565916.HKD","ALNY","ATTR","BK4585","BK4548","PBE","LU0320765992.SGD","BK4139","BK4588","LU0114720955.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648504160","title":"Acoramidis Associated with First-Ever Early and Sustained Direct Kidney-Protective Effects in ATTR-CM","url":"https://stock-news.laohu8.com/highlight/detail?id=2648504160","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648504160?lang=en_us&edition=fundamental","pubTime":"2026-07-02 19:30","pubTimestamp":1782991800,"startTime":"0","endTime":"0","summary":"- Acoramidis initiation was associated with rapid kidney-protective activity as exhibited in a hemodynamically mediated, reversible eGFR dip and a placebo-corrected 15.5% reduction in UACR by Day 28 (","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/02/3321249/0/en/Acoramidis-Associated-with-First-Ever-Early-and-Sustained-Direct-Kidney-Protective-Effects-in-ATTR-CM.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATTR","BK4207","BK4081","CM","EMA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642406644","title":"DKSH Partners with BridgeBio to Distribute ATTR-CM Drug in Key Asia-Pacific Markets","url":"https://stock-news.laohu8.com/highlight/detail?id=2642406644","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642406644?lang=en_us&edition=fundamental","pubTime":"2026-06-11 13:33","pubTimestamp":1781156020,"startTime":"0","endTime":"0","summary":"An update from DKSH Holding AG ( ($CH:DKSH) ) is now available. DKSH’s Healthcare unit has entered a strategic distribution partnership with U.S. b...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/dksh-partners-with-bridgebio-to-distribute-attr-cm-drug-in-key-asia-pacific-markets?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/dksh-partners-with-bridgebio-to-distribute-attr-cm-drug-in-key-asia-pacific-markets?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4207","BK4585","BK4588","XBI","XLV","BK4581","CM","LABU","ATTR"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":45,"code":"91000000","status":"200"}]}}